Metronet Names New CEO, CFO
Company Executes Succession Plan; Prepares for Future Growth EVANSVILLE, Ind.–(BUSINESS WIRE)–Metronet announced today the advancement…
Company Executes Succession Plan; Prepares for Future Growth EVANSVILLE, Ind.–(BUSINESS WIRE)–Metronet announced today the advancement…
NEW YORK–(BUSINESS WIRE)–$RNW #ClimatePartnership–The US-India Strategic Partnership Forum (USISPF), and ReNew, in partnership with the…
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) — Epic Bio, a biotechnology company…
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) — Epic Bio, a biotechnology company…
As of June 30, 2023 Cash position of €12.1 million (€17.4 million as of December…
– Vast high-throughput screening study used to train unique machine learning algorithm to design synthetic…
Additional Providers Increase Biospecimen Access for Researchers Focused on Cervical, Uterine and Breast Cancers, as…
Additional Providers Increase Biospecimen Access for Researchers Focused on Cervical, Uterine and Breast Cancers, as…
-CRISPR Therapeutics co-founder, Rodger Novak, M.D., to step down as President and Chairman, effective September…
-CRISPR Therapeutics co-founder, Rodger Novak, M.D., to step down as President and Chairman, effective September…
Company to Focus on Core Revenue Drivers, New Revenue Growth Opportunities from Recently Launched Sequencing…
CAMBRIDGE, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage…
CAMBRIDGE, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage…
~ Revenues of $491.1 million ~ ~ GAAP Diluted Earnings Per Share of $1.72 ~…
Designed to demonstrate delivery of TTX-MC138 to metastatic lesions BOSTON, Aug. 23, 2023 (GLOBE NEWSWIRE)…
Designed to demonstrate delivery of TTX-MC138 to metastatic lesions BOSTON, Aug. 23, 2023 (GLOBE NEWSWIRE)…
Results demonstrate safety, biodistribution, and on-target editing of simian immunodeficiency virus (SIV) in non-human primates…
Results demonstrate safety, biodistribution, and on-target editing of simian immunodeficiency virus (SIV) in non-human primates…
New Capabilities Enable Platform to Efficiently Collect and Store Most Up-to-Date Data from Providers and…
New Capabilities Enable Platform to Efficiently Collect and Store Most Up-to-Date Data from Providers and…